The MATADOR Trial, Refeeds, and Diet Breaks: 2026 Evidence Review

What intermittent energy restriction protocols show — and where the popular framing oversells the science

What is the MATADOR trial and what did it find?

MATADOR (Minimising Adaptive Thermogenesis And Deactivating Obesity Rebound) was a 30-week randomized trial published by Byrne et al. in 2018. It compared continuous energy restriction with intermittent energy restriction in 51 obese men. The continuous group dieted at a 33% deficit for 16 weeks. The intermittent group followed a 2-weeks-deficit-then-2-weeks-maintenance pattern, accumulating the same total restriction time (16 weeks) over 30 calendar weeks.

The intermittent group lost more weight (14.1 kg vs 9.1 kg), more fat mass, and showed smaller reductions in resting energy expenditure. Six months post-intervention, the intermittent group also retained more of their loss.

This article reviews MATADOR and the surrounding intermittent energy restriction literature, distinguishes refeeds from diet breaks, and provides clinical guidance on when and how to use them.

Why this matters: Diet breaks have become a fixture of online weight-management advice, often with claims that overshoot the evidence. The actual literature supports a real, moderate effect — meaningful in athletes and competitive contexts, modest in general population weight loss. RDs and clinicians should know what the data actually show before integrating these protocols into care.

What is the difference between refeeds, diet breaks, and intermittent energy restriction?

These terms are often used interchangeably but describe different protocols:

The MATADOR protocol is closest to “intermittent energy restriction.” Diet breaks as commonly practiced (every 8-12 weeks for 1-2 weeks) are a less aggressive version of the same idea.

What does the broader IER literature show?

Headland et al. (2016) systematic review and meta-analysis included 40 trials of intermittent energy restriction. Findings:

• IER produces similar or slightly greater weight loss than continuous restriction at matched cumulative energy deficit
• Fat mass loss is similar
• Adherence is generally better in IER, particularly over longer protocols
• Metabolic rate adaptation is moderately reduced in some studies but the effect is heterogeneous

The takeaway: IER is at least non-inferior to continuous restriction for weight loss outcomes, with modestly better adherence and possibly attenuated adaptive thermogenesis. It is not a magical protocol. It is a useful structural alternative for patients who struggle with sustained continuous deficits.

Why does the intermittent pattern attenuate metabolic adaptation?

Three plausible mechanisms:

1. Hormonal recovery. During maintenance phases, leptin, T3, and other hormones suppressed by deficit partially recover. The body’s “starvation signaling” is interrupted before it consolidates.
2. Reduced cumulative cortisol exposure. Chronic deficits raise cortisol, which independently suppresses thyroid function and increases visceral fat retention. Maintenance phases reduce this.
3. Adherence support. Patients eating at maintenance for 2 weeks every 6 weeks are less likely to “fall off” the plan completely. Adherence-driven results compound.

The third mechanism is probably the most important in real-world settings. Patients who feel they are “always dieting” eventually quit. Patients with planned breaks have something to look forward to.

How should clinicians design a diet break?

A typical structured diet break protocol for a patient on a sustained deficit:

Phase 1: Deficit (8-12 weeks)

• 20-25% caloric deficit from estimated maintenance
• Protein at 1.4-1.6 g/kg IBW
• Resistance training 2-3x/wk
• Aerobic activity at usual level
• Daily or weekly weigh-ins for trend monitoring

Phase 2: Diet break (1-2 weeks)

• Calories increased to estimated maintenance (NOT a surplus, NOT “refeed-binge”)
• Protein maintained at deficit level
• Carbohydrate increase produces most of the calorie increase
• Training maintained
• Weight is expected to increase 1-2 kg during the break, primarily glycogen and water; this is normal, not regain

Phase 3: Return to deficit (8-12 weeks)

• Re-estimate maintenance calories — the patient is lighter than before the previous deficit phase, so the new deficit target is also lower
• 20-25% deficit from new maintenance
• Resume

Cycling rules:

• Take a diet break sooner if hunger, mood, sleep, or training output declines materially
• Skip a planned break if deficit is going well and patient prefers continuity
• Treat the maintenance phase as a practiced skill — the patient is learning how maintenance feels

What does a refeed day actually do?

A 1-2 day refeed at maintenance, primarily increasing carbohydrate, has more limited effects than a full diet break:

• Restores muscle glycogen
• Supports next training session quality
• Modestly elevates leptin acutely (effect transient, returns near baseline within 24-48 hours of resuming deficit)
• Provides psychological recovery from sustained restriction

It does not meaningfully alter metabolic rate over weeks. The popular framing of “refeed to boost metabolism” overstates a small acute effect. The clinical value of refeeds is mainly performance and adherence, not metabolic rescue.

Do diet breaks work in athletes?

Yes, with somewhat better evidence in this population. Trexler et al. (2014, 2022) and Peos et al. (2019) have explicitly framed diet breaks as part of athlete contest preparation. Campbell et al. (2020) demonstrated reduced fat-free mass loss with intermittent vs continuous restriction in resistance-trained women.

The athletic application:

• Long contest prep (greater than 12 weeks): diet breaks every 4-6 weeks
• Mid-prep stalls: a 2-week diet break often resolves them
• Post-show: extended diet break / “reverse diet” to recover hormonal markers
• Year-round body composition management: cyclical IER patterns

How do diet breaks interact with GLP-1 therapy?

Patients on GLP-1 medications often experience appetite suppression continuously, so the rationale for diet breaks is different. Mechanically scheduled “eat at maintenance” weeks may be useful for:

• Restoring lean mass at intervals during longer pharmacological weight loss
• Allowing periodic body composition assessment without active deficit
• Building maintenance practice for eventual off-ramping

Some clinicians use “stable weight intervals” of 2-4 weeks every 12-16 weeks during GLP-1 therapy, particularly in patients at higher risk of lean mass loss. The evidence base for this specifically is limited but the rationale is reasonable.

What does this look like for patients who are not athletes?

A practical, sustainable version for a typical adult on a 6-month weight loss intervention:

• Weeks 1-8: deficit phase, 20% restriction
• Weeks 9-10: diet break at maintenance
• Weeks 11-18: deficit phase, 20% restriction (recalculated maintenance)
• Weeks 19-20: diet break
• Weeks 21-26: deficit or transition to maintenance

This pattern produces several months of substantive deficit time with built-in recovery, supports adherence, and builds the maintenance skill the patient will need at the end of the intervention.

What are common pitfalls?

• Treating the diet break as a free-for-all. Eating at maintenance is not eating without restraint. Patients who treat breaks as binges undo the deficit gains.
• Skipping protein on the break. Protein should be maintained or increased; the break is for energy and adherence, not for backing off muscle preservation.
• Mistaking glycogen weight for fat regain. The 1-2 kg gain on a break is physiological, not failure. Patients need this framed in advance.
• Breaking too often. A 1-week break every 4 weeks is mostly maintenance; effective deficits become impossible.
• Breaking too rarely. A first break at week 16-20 of an unbroken deficit is often “too late” — adherence and hormonal markers have already drifted.

Are diet breaks better for women specifically?

The literature is smaller in women but suggests broadly similar direction of effect. Hormonal context matters: women in luteal phase often experience greater hunger and may benefit from luteal-phase-aligned breaks. Patients with PMS or PMDD, perimenopausal women, and women in HRT transitions may particularly benefit from cyclical patterns over continuous deficits.

For deeper consideration of weight management in women across life stages, future articles in the life-stage cluster will cover this in detail.

Bottom line

The MATADOR trial and surrounding intermittent energy restriction literature support diet breaks as a useful tool — modestly, not magically. The evidence base supports 1-2 weeks at maintenance every 4-12 weeks of deficit, with planned reductions in adaptive thermogenesis, improved adherence, and potential lean mass benefit. Refeed days are a smaller, primarily performance-oriented intervention. Both have a place in evidence-based weight management.

The popular framing of “diet breaks reset metabolism” overstates the science; the clinical reality is more measured. Used well, IER protocols help patients sustain deficits longer with less metabolic and psychological cost.

For closely related content, see adaptive thermogenesis and tracking plateaus and set-point theory in 2026. The glossary entry on energy balance covers underlying definitions.